Benicar Lawsuit Help
The Law Firm of Eric H. Weinberg is currently assisting individuals nationwide who have experienced intestinal problems known as sprue-like enteropathy after taking the antihypertensive Benicar (olmesartan medoxomil). Symptoms of sprue-like enteropathy can include severe, chronic diarrhea with substantial weight loss.
If you or a loved one was diagnosed with spruce-like enteropathy, experienced its symptoms, or experienced its symptoms with a similar intestinal disease diagnosis after taking Benicar, you may wish to call our firm toll free at 1-877-934-6274 for a free and non-obligatory legal case evaluation. You can also contact us online by submitting the “Free Legal Case Evaluation Form” found on this page. Let us help you take the first steps toward seeking compensation for your injuries
FDA Safety Announcement – Spruce-like Enteropathy Linked to Benicar
On July 3, 2013, The U.S. Food and Drug Administration (FDA) warned that the blood pressure medication olmesartan medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generic versions) can cause intestinal problems known as sprue-like enteropathy.
More About Benicar and Spruce-like Enteropathy
According to the FDA, sprue-like enteropathy symptoms can include severe, chronic diarrhea with substantial weight loss. The enteropathy may develop months to years after starting Benicar (olmesartan), and sometimes requires hospitalization.
Put Your Health First – If you are taking Benicar or another olmesartan-containing product, and you have a concern or question regarding your health, talk to your doctor or health care professional. Always talk to you doctor before stopping or changing medications, including Benicar which is prescribed to treat high blood pressure.
Why is Benicar (olmesartan medoxomil) prescribed?
Benicar (olmesartan medoxomil) is an angiotensin II receptor blocker (ARB) approved for the treatment of high blood pressure, alone or in combination with other antihypertensive agents. It is one of eight marketed ARB drugs. According to the FDA, “Sprue-like enteropathy has not been detected with ARB drugs other than olmesartan”. Benicar, Benicar HCT, Azor, and Tribenzor are marketed by Daiichi Sankyo, Inc., headquartered in Parsippany, NJ. Forest Laboratories Inc., also headquartered in Parsippany, NJ, entered co-promotional agreements with Daiichi Sankyo regarding the Benicar and Azor products.
Benicar Lawsuits Have Been Centralized to New Jersey Federal Court
The U.S. Judicial Panel on Multidistrict Litigation has centralized Benicar Lawsuits to Federal Court in New Jersey, the state in which defendants Daiichi Sankyo Inc., and Forest Laboratories Inc., are headquartered. This litigation has been assigned to the Honorable Robert B. Kugler in The United States District Court for the District of New Jersey (D.N.J.). The case is In Re: Benicar (Olmesartan) Products Liability Litigation, MDL No. 2606, in the United States Judicial Panel on Multidistrict Litigation.
Multiple state court cases are also pending in New Jersey.
Contact the Law Firm of Eric H. Weinberg for a Free Benicar Lawsuit Evaluation
The New Brunswick, New Jersey, Law Firm of Eric Weinberg has represented thousands of patients injured by pharmaceutical drugs including for example, Vioxx, Baycol, Pradaxa, Ortho Evra, and blood clotting products. If you or a loved one was diagnosed with spruce-like enteropathy, including severe diarrhea, chronic diarrhea, or significant weight loss; or you experienced these symptoms with a diagnosis of diverticulitis, irritable bowel syndrome (IBS), celiac disease, Crohn’s Disease, or colitis while taking Benicar, and you would like a free legal case evaluation, please call the Weinberg Law Firm toll free at 1-877-934-6274. Our phones are answered 24/7.
